Structures by: Jetti R. K.
Total: 66
Phenobarbital dioxane hemisolvate
C12H12N2O3,0.5(C4H8O2)
The journal of physical chemistry. B (2014) 118, 12 3267-3280
a=6.86417(15)Å b=11.9645(2)Å c=16.6842(4)Å
α=90° β=98.071(2)° γ=90°
Phenobarbital dichloromethane monosolvate
C12H12N2O3,CH2Cl2
The journal of physical chemistry. B (2014) 118, 12 3267-3280
a=8.6980(5)Å b=11.9681(6)Å c=14.2590(7)Å
α=90.00° β=97.470(5)° γ=90.00°
Phenobarbital nitromethane monosolvate
C12H12N2O3,CH3NO2
The journal of physical chemistry. B (2014) 118, 12 3267-3280
a=10.2543(14)Å b=10.4086(15)Å c=13.7090(19)Å
α=98.774(11)° β=96.171(11)° γ=98.962(3)°
Phenobarbital dioxane monosolvate
C12H12N2O3,C4H8O2
The journal of physical chemistry. B (2014) 118, 12 3267-3280
a=10.6052(3)Å b=10.5502(2)Å c=14.6810(4)Å
α=90° β=92.028(2)° γ=90°
Phenobarbital dioxane monosolvate
C12H12N2O3,C4H8O2
The journal of physical chemistry. B (2014) 118, 12 3267-3280
a=17.639(2)Å b=10.4165(8)Å c=18.374(2)Å
α=90.00° β=108.281(9)° γ=90.00°
Phenobarbital acetonitrile monosolvate
C12H12N2O3,C2H3N
The journal of physical chemistry. B (2014) 118, 12 3267-3280
a=10.1600(7)Å b=10.3036(11)Å c=14.0553(12)Å
α=99.674(8)° β=96.774(6)° γ=97.811(7)°
2,4,6-tris-(4-methylphenoxy)-1,3,5-triazine
C24H21N3O3
Chemical Communications (1999) 17 1639
a=23.576(3)Å b=23.576(3)Å c=6.5913(8)Å
α=90.00° β=90.00° γ=120.00°
4-aminothiphenol
C6H7NS
Chemical Communications (2004) 22 2526-2527
a=7.2305(12)Å b=5.8513(10)Å c=7.7552(13)Å
α=90.00° β=107.364(3)° γ=90.00°
2,4,6-Tris-(4-nitrophenoxy)-1,3,5-triazine, Hexachlorobenzene solvate
C27H12Cl6N6O9
Chemical Communications (2002) 9 952
a=14.6600(8)Å b=14.6600(8)Å c=20.2098(16)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-Tris-(4-nitrophenoxy)-1,3,5-triazine, Benzene solvate
C48H30N12O18
Chemical Communications (2002) 9 952
a=14.195(2)Å b=14.195(2)Å c=20.941(5)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-Tris-(4-nitrophenoxy)-1,3,5-triazine, Tribromobenzene solvate
C27H15Br3N6O9
Chemical Communications (2002) 9 952
a=14.5236(11)Å b=14.5236(11)Å c=8.2878(9)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-Tris-(4-nitrophenoxy)-1,3,5-triazine, Hexamethylbenzene solvate
C75H54N18O27
Chemical Communications (2002) 9 952
a=14.4433(8)Å b=14.4433(8)Å c=22.5930(18)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris-(4-chlorophenoxy)-1,3,5-triazine, triiodobenzene clathrate
(C21H12N3O3Cl3).(C6H3I3)
Chemical Communications (2001) 10 919
a=15.4817(6)Å b=15.4817(6)Å c=7.0107(4)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris-(4-bromophenoxy)-1,3,5-triazine, tribromobenzene clathrate
(C21H12N3O3Br3).(C6H3Br3)
Chemical Communications (2001) 10 919
a=15.4420(13)Å b=15.4420(13)Å c=6.9909(7)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris-(4-bromophenoxy)-1,3,5-triazine, triiodobenzene clathrate
(C21H12N3O3Br3).(C6H3I3)
Chemical Communications (2001) 10 919
a=15.6268(16)Å b=15.6268(16)Å c=7.0464(10)Å
α=90.00° β=90.00° γ=120.00°
4-iodoaniline
C6H6IN
CrystEngComm (2003) 5, 43 248
a=8.422(7)Å b=4.965(4)Å c=8.645(7)Å
α=90.00° β=109.790(13)° γ=90.00°
4-ethynylaniline
C8H7N
CrystEngComm (2003) 5, 43 248
a=10.423(4)Å b=7.033(3)Å c=8.951(4)Å
α=90.00° β=90.00° γ=90.00°
4-bromoaniline
C6H5BrN
CrystEngComm (2003) 5, 43 248
a=8.594(2)Å b=7.6166(19)Å c=9.469(2)Å
α=90.00° β=90.00° γ=90.00°
2,4,6-Tris-(4-nitrophenoxy)-1,3,5-triazine, Chloroform solvate
C24H15Cl9N6O9
Chemical Communications (2002) 9 952
a=14.6173(11)Å b=14.6173(11)Å c=8.3838(8)Å
α=90.00° β=90.00° γ=120.00°
4-(triphenylmethyl)benzoic acid p-xylene clathrate
(C26H20O2).0.5(C8H10)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.241(2)Å b=9.011(2)Å c=18.916(3)Å
α=84.25(2)° β=87.25(2)° γ=66.66(2)°
4-(triphenylmethyl)benzoic acid mesitylene clathrate
(C26H20O2).(C9H12)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.390(1)Å b=13.637(1)Å c=14.349(1)Å
α=75.92(1)° β=81.64(1)° γ=85.16(1)°
4-(triphenylmethyl)benzoic acid xylene clathrate
(C26H20O2).0.5(C8H10)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.3270(10)Å b=9.042(2)Å c=18.534(4)Å
α=88.09(3)° β=85.07(3)° γ=68.07(3)°
4-(triphenylmethyl)benzoic acid chlorobenzene clathrate
(C26H20O2).0.5(C6H5Cl)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.3100(10)Å b=8.9940(10)Å c=18.454(2)Å
α=89.190(10)° β=85.750(10)° γ=68.230(10)°
4-(triphenylmethyl)benzoic acid m-xylene clathrate
(C26H20O2).0.5(C8H10)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.329(1)Å b=9.044(1)Å c=18.547(1)Å
α=88.54(1)° β=85.33(1)° γ=67.63(1)°
4-(triphenylmethyl)benzoic acid o-xylene clathrate
(C26H20O2).0.5(C8H10)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.368(1)Å b=9.010(1)Å c=18.522(1)Å
α=88.00(1)° β=84.97(1)° γ=67.94(1)°
4-(triphenylmethyl)benzoic acid anisole clathrate
(C26H20O2).0.5(C7H8O)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.310(1)Å b=8.998(1)Å c=18.464(1)Å
α=89.98(1)° β=86.26(1)° γ=67.50(1)°
4-(triphenylmethyl)benzoic acid bromobenzene clathrate
(C26H20O2).0.5(C6H5Br)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.3066(2)Å b=8.9943(2)Å c=18.4963(5)Å
α=89.764(1)° β=85.946(1)° γ=67.868(1)°
4-(triphenylmethyl)benzoic acid nitrobenzene clathrate
(C26H20O2).0.5(C6H5NO2)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.340(2)Å b=8.982(2)Å c=18.366(4)Å
α=89.33(3)° β=86.14(3)° γ=67.55(3)°
2,4,6-tris-(4-chlorophenoxy)-1,3,5-triazine tribromobenzene
C21H12Cl3N3O3,C6H3Br3
Acta Crystallographica Section B (2000) 56, 6 1080-1084
a=15.250(2)Å b=15.250(2)Å c=6.8149(14)Å
α=90.00° β=90.00° γ=120.00°
C21H12Cl3N3O3,C6H3Br3
C21H12Cl3N3O3,C6H3Br3
Acta Crystallographica Section B (2000) 56, 6 1080-1084
a=15.166(6)Å b=15.166(6)Å c=6.743(2)Å
α=90.° β=90.° γ=120.°
Tris-(4-Tolyl)phenylmethane
C28H26
Acta Crystallographica Section C (2000) 56, 6 e259-e259
a=17.843(4)Å b=7.2015(14)Å c=33.176(7)Å
α=90.00° β=95.59(3)° γ=90.00°
3,4,5-Triiodotetraphenylmethane
C25H17I3
Acta Crystallographica Section C (2004) 60, 5 o331-o333
a=11.567(4)Å b=12.833(4)Å c=17.572(6)Å
α=108.031(6)° β=95.774(6)° γ=111.805(6)°
1:1 complex of bis(4-aminophenyl)disulfide and 4-aminothiophenol
C12H12N2S2,C6H7N1S1
Acta Crystallographica Section C (2002) 58, 10 o635-o636
a=15.210(3)Å b=6.0099(11)Å c=19.683(4)Å
α=90.00° β=96.814(3)° γ=90.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, dichloromethane
2(C21H12N3O3I3),CH2Cl2
Crystal Growth & Design (2005) 5, 3 887
a=15.7177(5)Å b=15.7177(5)Å c=18.9157(9)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-bromophenoxy)-1,3,5-triazine, hexafluorobenzene
2(C21H12Br3N3O3),C6F6
Crystal Growth & Design (2005) 5, 3 887
a=15.1070(9)Å b=15.1070(9)Å c=18.019(2)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, diiodomethane
C22H14I5N3O3
Crystal Growth & Design (2005) 5, 3 887
a=15.6962(10)Å b=15.6962(10)Å c=18.9478(18)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, hexachlorobenzene
2(C21H12I3N3O3),C6Cl6
Crystal Growth & Design (2005) 5, 3 887
a=15.686(4)Å b=15.686(4)Å c=18.583(7)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, collidine
2(C21H12I3N3O3),C8H11N
Crystal Growth & Design (2005) 5, 3 887
a=15.619(2)Å b=15.619(2)Å c=18.361(4)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, mesitylene
2(C21H12I3N3O3),C9H12
Crystal Growth & Design (2005) 5, 3 887
a=15.668(3)Å b=15.668(3)Å c=18.475(5)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, dibromomethane
C45H30Br3I6N6O6
Crystal Growth & Design (2005) 5, 3 887
a=15.6595(13)Å b=15.6595(13)Å c=18.681(2)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, tribromomesitylene
2(C21H12I3N3O3),C9H9Br3
Crystal Growth & Design (2005) 5, 3 887
a=15.7356(8)Å b=15.7356(8)Å c=18.3863(13)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, hexafluorobenzene
2(C21H12I3N3O3),C6F6
Crystal Growth & Design (2005) 5, 3 887
a=15.5466(4)Å b=15.5466(4)Å c=18.1511(11)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, 1,3,5-triiodomesitylene
2(C21H12I3N3O3),C9H9I3
Crystal Growth & Design (2005) 5, 3 887
a=15.9236(9)Å b=15.9236(9)Å c=18.425(2)Å
α=90.00° β=90.00° γ=120.00°
2,4,6-tris(4-iodophenoxy)-1,3,5-triazine, 1-methylnapthalene
2(C21H12N3O3I3),C11H10
Crystal Growth & Design (2005) 5, 3 887
a=15.5830(6)Å b=15.5830(6)Å c=18.3563(14)Å
α=90.00° β=90.00° γ=120.00°
Temazepam
C16H13ClN2O2
Crystal Growth & Design (2011) 11, 6 2039
a=13.144(3)Å b=13.454(3)Å c=31.573(6)Å
α=90.00° β=90.00° γ=90.00°
Temazepam
C16H13ClN2O2
Crystal Growth & Design (2011) 11, 6 2039
a=9.789(2)Å b=12.235(2)Å c=13.586(3)Å
α=101.60(3)° β=104.53(3)° γ=98.76(3)°
4-amino-1,2,4-triazole hydrochloride
C2H5ClN4
Crystal Growth & Design (2006) 6, 2 404
a=7.1584(14)Å b=8.1640(16)Å c=9.3954(19)Å
α=90.00° β=102.97(3)° γ=90.00°
1-aminoimidazole hydrochloride
C3H6ClN3
Crystal Growth & Design (2006) 6, 2 404
a=9.3559(19)Å b=4.9432(10)Å c=12.182(2)Å
α=90.00° β=97.76(3)° γ=90.00°
1-amino-1,2,4-triazole hydrochloride
C2H5ClN4
Crystal Growth & Design (2006) 6, 2 404
a=5.0990(10)Å b=7.2298(14)Å c=15.042(3)Å
α=90.00° β=96.52(3)° γ=90.00°
1,3-diamino-1,2,3-triazolium chloride
C2H6ClN5
Crystal Growth & Design (2006) 6, 2 404
a=5.5395(12)Å b=13.402(3)Å c=7.7150(10)Å
α=90.000(5)° β=90.000(5)° γ=90.000(5)°
1,4-diamino-1,2,4-triazolium chloride
C2H6ClN5
Crystal Growth & Design (2006) 6, 2 404
a=5.6109(5)Å b=6.7780(9)Å c=16.3497(5)Å
α=90.00° β=90.00° γ=90.00°
1-amino-1,2,3-triazole hydrochloride
C2H5ClN4
Crystal Growth & Design (2006) 6, 2 404
a=5.0579(3)Å b=7.0018(3)Å c=7.6470(5)Å
α=90.00° β=91.716(3)° γ=90.00°
6-amino-2-(2-chlorophenylsulfonylimino)-1,2-dihydropyridine
C11H10ClN3O2S
Crystal Growth & Design (2004) 4, 4 701
a=9.232(6)Å b=8.900(6)Å c=15.102(9)Å
α=90.00° β=96.081(11)° γ=90.00°
6-amino-2-(2-methylphenylsulfonylimino)-1,2-dihydropyridine
C12H13N3O2S
Crystal Growth & Design (2004) 4, 4 701
a=9.169(2)Å b=8.867(2)Å c=15.222(4)Å
α=90.00° β=96.511(5)° γ=90.00°
6-amino-2-(3-methylphenylsulfonylimino)-1,2-dihydropyridine
C12H13N3O2S
Crystal Growth & Design (2004) 4, 4 701
a=12.434(4)Å b=10.396(4)Å c=9.113(3)Å
α=90.00° β=92.247(6)° γ=90.00°
6-amino-2-(4-fluorophenylsulfonylimino)-1,2-dihydropyridine
C11H10FN3O2S
Crystal Growth & Design (2004) 4, 4 701
a=9.000(6)Å b=8.618(6)Å c=14.643(10)Å
α=90.00° β=91.698(17)° γ=90.00°
6-amino-2-(4-chlorophenylsulfonylimino)-1,2-dihydropyridine
C11H10ClN3O2S
Crystal Growth & Design (2004) 4, 4 701
a=13.725(6)Å b=7.312(3)Å c=25.419(11)Å
α=90.00° β=92.886(8)° γ=90.00°
6-amino-2-(4-bromophenylsulfonylimino)-1,2-dihydropyridine
C11H10BrN3O2S
Crystal Growth & Design (2004) 4, 4 701
a=10.7951(9)Å b=18.2559(15)Å c=26.335(2)Å
α=90.00° β=94.330(2)° γ=90.00°
6-amino-2-(4-iodophenylsulfonylimino)-1,2-dihydropyridine
C11H10IN3O2S
Crystal Growth & Design (2004) 4, 4 701
a=10.755(2)Å b=18.300(3)Å c=26.828(5)Å
α=90.00° β=90.00° γ=90.00°
6-amino-2-(4-methylphenylsulfonylimino)-1,2-dihydropyridine
C12H13N3O2S
Crystal Growth & Design (2004) 4, 4 701
a=15.015(6)Å b=10.880(5)Å c=17.066(7)Å
α=90.00° β=113.457(8)° γ=90.00°
6-amino-2-(4-methoxyphenylsulfonylimino)-1,2-dihydropyridine
C12H13N3O3S
Crystal Growth & Design (2004) 4, 4 701
a=10.614(3)Å b=18.276(5)Å c=27.402(7)Å
α=90.00° β=90.00° γ=90.00°
6-amino-2-(4-methylphenylsulfonylimino)-1,2-dihydropyridine
C12H13N3O2S
Crystal Growth & Design (2004) 4, 4 701
a=10.834(3)Å b=17.749(4)Å c=26.473(7)Å
α=90.00° β=94.531(7)° γ=90.00°
6-amino-2-(4-nitrophenylsulfonylimino)-1,2-dihydropyridine
C11H12N4O5S
Crystal Growth & Design (2004) 4, 4 701
a=14.663(16)Å b=12.276(16)Å c=7.589(11)Å
α=90.00° β=96.16(9)° γ=90.00°
4-(triphenylmethyl)benzoic acid, unsolvated form
C26H20O2
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.390(2)Å b=15.477(2)Å c=33.858(2)Å
α=90.00° β=90.00° γ=90.00°
1,3-diaminoimidazolium chloride
C3H7ClN4
Crystal Growth & Design (2006) 6, 2 404
a=4.6613(2)Å b=16.2967(4)Å c=7.8232(5)Å
α=90.00° β=98.524(3)° γ=90.00°
6-amino-2-[4-(trifluoromethyl)phenylsulfonylimino]-1,2-dihydropyridine
C12H10F3N3O2S
Crystal Growth & Design (2004) 4, 4 701
a=10.8897(13)Å b=18.343(2)Å c=26.640(3)Å
α=90.00° β=90.00° γ=90.00°